drugset / Trial / NCT00269984
A Study to Determine the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia Caused by Advanced Cancer
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the safety and effectiveness of epoetin alfa versus placebo, injected beneath the skin, in the treatment of patients with persistent anemia caused by advanced cancer, with a below normal hematocrit of \<= 37%. Epoetin alfa is a genetically engineered protein that stimulates red blood cell production.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- 1990-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | epoetin alfa | Protein / enzyme biologic | 100 iu/kg | Subcutaneous |
| Subject | epoetin alfa | Protein / enzyme biologic | 150 iu/kg | Subcutaneous |